Neogen Chemicals shines on inking pact to acquire 100% stake in BuLi Chem from Livent

Neogen Chemicals shines on inking pact to acquire 100% stake in BuLi Chem from Livent

by 5paisa Research Team Last Updated: Mar 06, 2023 - 05:27 pm 1.3k Views
Listen icon

Shares of Neogen Chemicals Limited have gained more than 6% in today’s trade.

Agreement with Livent Corporation

Neogen Chemicals has entered into a definitive agreement with Livent Corporation to acquire 100% stake in BuLi Chemicals India (BuLi Chem) from Livent. BuLi Chem owns the technology to manufacture N Butyl Lithium and other organolithium products using lithium metal, which are key reagents for lithiation reaction used in manufacturing of several complex pharmaceutical and agrochemical intermediates.

BuLi Chem manufactures and supplies N Butyl Lithium to several leading pharma and agrochemical companies in India and across the world and is built one of the very few commercial facilities outside of China for this chemistry.

This acquisition will boost Neogen’s portfolio by offering organolithium derivatives to existing pharma and agrochemical industries and further enhance its advanced intermediates & CSM manufacturing business.

Share price movement of Shree Cement Limited

Today, the stock opened at Rs 1315.40, with a high and low of Rs 1386 and Rs 1315.40. The stock closed trading at Rs 1374.15, up by 6.56%.

The stock has a 52-week high of Rs 1792.00 and a 52-week low of Rs 1127. The company has a ROCE of 14.2% with a market capitalisation of Rs 3,428 crore.

Company profile

Neogen Chemicals is one of India’s leading manufacturers of bromine-based, and lithium-based, specialty chemicals. The company manufactures specialty organic bromine-based chemical compounds (Bromine Compounds) and other specialty organic chemical compounds as well as specialty inorganic lithium-based chemicals compounds (Lithium Compounds and together with the Bromine Compounds the Products). In addition to manufacturing its standard products, the company also undertakes custom synthesis and contract manufacturing.

Share Market Today


How do you rate this article?

Start Investing in 5 mins*

Rs. 20 Flat Per Order | 0% Brokerage

378X91-D3

About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.

Disclaimer

Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial.
Enjoy 0%* Brokerage with 5paisa
Resend OTP
Please Enter OTP
Mobile No. belongs to

By proceeding, you agree to the T&C.

Latest News
Trust Fintech IPO Subscribed 108.63 times

Trust Fintech IPO is book-built issue of ₹63.45 crores, consisting entirely of fresh issue shares totalling 62.82 lakh. Trust Fintech IPO commenced its subscription period on March 26, 2024, & concludes today, March 28, 2024.

Aspire & Innovative IPO Subscribed 15.17 times

Aspire & Innovative IPO is a book built issue of Rs 21.97 crores. The issue comprises entirely a fresh issue of 40.68 lakh shares. Aspire & Innovative IPO opens for subscription on March 26, 2024, and closes on March 28, 2024. The allotment for the Aspire & Innovative IPO is expected to be finalized on Monday, April 1, 2024.

Blue Pebble IPO Subscribed 56.32 times

Blue Pebble IPO, valued at ₹18.14 crores, comprises fresh issue of 10.8 lakh shares. Commencing subscription on March 26, 2024, Blue Pebble IPO is set to conclude on March 28, 2024. Allotment process is scheduled to be finalized by Monday, April 1, 2024. Following this, IPO is slated to debut on NSE SME, with tentative listing date of Wednesday, April 3, 2024.